Evidence map›Paper›PMID 32461309›Full record

ArticleJournal of virology2020

Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.

S Mediouni, J A Jablonski, S Tsuda, A Barsamian, C Kessing, A Richard, A Biswas, F Toledo, V M Andrade, Y Even and 6 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. The Antiviral Potential ofMolecules (Basel, Switzerland) · 2024
    Pooled it
  2. Article
  3. Article
  4. Antiviral Activity ofBiomedicines · 2025
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Mexican Oregano (Molecules (Basel, Switzerland) · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

S Mediouni *Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
J A Jablonski *Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
S TsudaDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
A BarsamianDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA.
C KessingDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
A RichardDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
A BiswasDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
F ToledoDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
V M AndradeUniversity of Miami Miller School of Medicine, Miami, Florida, USA.ORCID 0000-0002-5056-298X
Y EvenThe Botanist's Beach Farm, Hobe Sound, Florida, USA.
M StevensonUniversity of Miami Miller School of Medicine, Miami, Florida, USA.
T TellinghuisenDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
H ChoeDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA.
M CameronDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA.
T D BannisterDepartment of Molecular Medicine, The Scripps Research Institute, Jupiter, Florida, USA.
S T ValenteDepartment of Immunology and Microbiology, The Scripps Research Institute, Jupiter, Florida, USA svalente@scripps.edu.
Scripps Research Institute · USUniversity of Miami · USHobe Sound Bible College · US

Funding

Mode of action of a new Tat HIV-1 inhibitorR01AI097012 · NIAID · UNIVERSITY OF FLORIDA · PI VALENTE, SUSANA T · 2012 to 2022
$7.5M
NIAID NIH HHS R01 AI097012
6 · The paper itself

Abstract

Oregano essential oil has long been known for its health-promoting benefits. Here, we report its activity against viral replication. Oregano oil was found to specifically inhibit lentiviruses, such as human and simian immunodeficiency viruses (HIV and SIV), irrespective of virus tropism, but not hepatitis C virus, adenovirus 5 (ADV5), Zika virus, and influenza (H1N1) virus. Oregano oil's most abundant components, carvacrol and its isomer, thymol, were shown to block virus-target cell fusion while not perturbing other stages of the virus life cycle. We detected changes in virus particle density, suggesting that cholesterol depletion from the HIV-1 envelope membrane reduces virus entry. Furthermore, infection was rescued by adding exogenous cholesterol. The evolution of viral resistance to carvacrol supported this mechanism of action with the identification of mutations in the viral gp41 fusion protein that counteracted cholesterol depletion. In addition, resistance to carvacrol emerged later than typically observed for other clinically used drugs, strengthening its antiviral potential. Structure-activity relationship studies revealed key motifs of carvacrol and thymol required for HIV neutralization and identified previously unknown active analogs. Carvacrol was also shown to additively cooperate with antiretroviral therapy. In sum, oregano oil and improved carvacrol and thymol analogs could be considered to supplement current HIV therapeutics.

Indexed as

AnimalsCholesterolCymenesDrug Resistance, ViralHeLa CellsHIV-1HIV Envelope Protein gp41HIV InfectionsHumansMacaca mulattaMutationOriganumPlant OilsVirus InternalizationcarvacrolCholesterolCymenesgp41 protein, Human immunodeficiency virus 1HIV Envelope Protein gp41Plant Oilscarvacrolcholesterol depletionentry inhibitionhuman immunodeficiency virusoregano oilthymolviral membrane

Identifiers

PMID32461309
PMCPMC7375364
OpenAlexW3026806921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.